Skip to content
★ Sign in to follow
BE

Bengt Erlandsson

Cinclus Pharma Holding AB (publ)
Total declarations
3
Company
1
▲ Purchases (3 ops.)
€12k
▼ Sales (0 ops.)
—

Latest filing published 12 Jul 2024 for Cinclus Pharma Holding AB (publ), €1,467.

Filing timeline

BuySale
Bengt Erlandsson

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-14.1%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Bengt Erlandsson: trading record in brief

This profile gathers the share dealings of Bengt Erlandsson in Cinclus Pharma Holding AB (publ). Between 20 June 2024 and 12 July 2024, the trades on record add up to 3 filings.

On the market, this insider has only ever bought: 3 purchases, €12k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €5,417. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -14.1%, with the price up in 0% of them. This is a record of the past, not a forecast.

The newest entry dates from 12 July 2024: an open-market purchase of €1,467, in Cinclus Pharma Holding AB (publ). Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Bengt Erlandsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Annan ledande befattningshavareExecutivesCinclus Pharma Holding AB (publ)
    16,750 SEK21FI-SE
    500 shares@ SEK 33.5011.8% of flowAktieISIN SE0020388577FI:csv-55d1ad7d8dd2f2b93dd6
    Canonical exit: 10 Oct 2024 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesCinclus Pharma Holding AB (publ)
    62,725 SEK29FI-SE
    1,895 shares@ SEK 33.1044.7% of flowAktieISIN SE0020388577FI:csv-0264c0fe88e6971832d4
    Canonical exit: 23 Sept 2024 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesCinclus Pharma Holding AB (publ)
    60,900 SEK29FI-SE
    1,450 shares@ SEK 42.0043.5% of flowAktieISIN SE0020388577FI:csv-c1e530d31a1f73090e43
    Canonical exit: 18 Sept 2024 (T+90)

3 of 3 declarations